TMDX
TMDX
NASDAQ · Health Care

Transmedics Group Inc

$105.13
-3.79 (-3.48%)
As of Mar 25, 9:55 PM ET ·
Financial Highlights (FY 2026)
Revenue
553.67M
Net Income
174.00M
Gross Margin
59.9%
Profit Margin
31.4%
Rev Growth
+86.4%
D/E Ratio
1.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.9% 59.9% 41.3% 41.3%
Operating Margin 17.9% 16.1% 8.1% 9.9%
Profit Margin 31.4% 29.9% 6.6% 8.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 553.67M 297.00M 2.67B 2.60B
Gross Profit 331.76M 177.96M 1.10B 1.07B
Operating Income 99.27M 47.93M 215.76M 258.19M
Net Income 174.00M 84.01M 176.17M 221.55M
Gross Margin 59.9% 59.9% 41.3% 41.3%
Operating Margin 17.9% 16.1% 8.1% 9.9%
Profit Margin 31.4% 29.9% 6.6% 8.5%
Rev Growth +86.4% +86.4% -8.6% +8.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.25B 1.25B 1.93B 1.88B
Total Equity 1.15B 1.15B 2.11B 1.74B
D/E Ratio 1.08 1.08 0.92 1.08
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 99.76M 50.84M 309.48M 247.18M
Free Cash Flow 251.22M 206.55M